TY - JOUR
T1 - Mortality of Gastrointestinal Cancers Attributable to Smoking, Alcohol, and Metabolic Risk Factors, and its Association With Socioeconomic Development Status 2000-2021
AU - Danpanichkul, Pojsakorn
AU - Suparan, Kanokphong
AU - Pang, Yanfang
AU - Auttapracha, Thanida
AU - Tham, Ethan Kai Jun
AU - Srisurapanont, Karan
AU - Uawithya, Ekdanai
AU - Worapongpaiboon, Rinrada
AU - Attachaipanich, Tanawat
AU - Lim, Ryan Yan Zhe
AU - Noureddin, Mazen
AU - Singal, Amit G.
AU - Liangpunsakul, Suthat
AU - Wallace, Michael B.
AU - Yang, Ju Dong
AU - Wijarnpreecha, Karn
N1 - Publisher Copyright:
© 2024 Elsevier Inc.
PY - 2025/5
Y1 - 2025/5
N2 - Objective: Gastrointestinal (GI) cancers account for one-third of global cancer mortality, with nearly half being preventable. This study updates the global burden of GI cancers attributed to major risk factors. Methods: We utilized data from the Global Burden of Disease Study 2021 to examine trends in death and age-standardized death rates related to GI cancers caused by smoking, alcohol, high body mass index (BMI), and high fasting blood glucose (FBG) from 2000 to 2021. Trends were analyzed based on countries' developmental status using a sociodemographic index (SDI). Results: In 2021, there were 1.12 million GI cancer deaths related to smoking, alcohol, high BMI, and high FBG, which was 53.6% higher than in 2000. The largest proportion of GI cancer mortality was attributed to smoking (43.3%), followed by alcohol (20.6%), high FBG (20.5%), and high BMI (15.6%). The increases in GI cancer deaths between 2000 and 2021 were related to high BMI (+102.54%) and FBG (+107.69%), particularly in liver and pancreatic cancer. In 2021, GI cancer mortality in low, low-middle, and middle SDI countries represented 44.3% of the global GI cancer mortality attributed to smoking, 41.9% for alcohol, 34.3% for high BMI, and 31.6% for high FBG. Since 2000, these proportions have increased by +4.5% for smoking, +7.6% for alcohol, + 12.3% for high BMI, and +6.4% for high FBG. Conclusion: From 2000 to 2021, GI cancer mortality increased substantially, driven primarily by obesity and alcohol. Lower SDI countries are increasingly contributing to the global GI cancer burden.
AB - Objective: Gastrointestinal (GI) cancers account for one-third of global cancer mortality, with nearly half being preventable. This study updates the global burden of GI cancers attributed to major risk factors. Methods: We utilized data from the Global Burden of Disease Study 2021 to examine trends in death and age-standardized death rates related to GI cancers caused by smoking, alcohol, high body mass index (BMI), and high fasting blood glucose (FBG) from 2000 to 2021. Trends were analyzed based on countries' developmental status using a sociodemographic index (SDI). Results: In 2021, there were 1.12 million GI cancer deaths related to smoking, alcohol, high BMI, and high FBG, which was 53.6% higher than in 2000. The largest proportion of GI cancer mortality was attributed to smoking (43.3%), followed by alcohol (20.6%), high FBG (20.5%), and high BMI (15.6%). The increases in GI cancer deaths between 2000 and 2021 were related to high BMI (+102.54%) and FBG (+107.69%), particularly in liver and pancreatic cancer. In 2021, GI cancer mortality in low, low-middle, and middle SDI countries represented 44.3% of the global GI cancer mortality attributed to smoking, 41.9% for alcohol, 34.3% for high BMI, and 31.6% for high FBG. Since 2000, these proportions have increased by +4.5% for smoking, +7.6% for alcohol, + 12.3% for high BMI, and +6.4% for high FBG. Conclusion: From 2000 to 2021, GI cancer mortality increased substantially, driven primarily by obesity and alcohol. Lower SDI countries are increasingly contributing to the global GI cancer burden.
KW - Cancer
KW - Epidemiology
KW - Gastroenterology
KW - Obesity
KW - Oncology
KW - Public health
UR - http://www.scopus.com/inward/record.url?scp=85219140548&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85219140548&partnerID=8YFLogxK
U2 - 10.1016/j.amjmed.2024.12.019
DO - 10.1016/j.amjmed.2024.12.019
M3 - Article
C2 - 39778787
AN - SCOPUS:85219140548
SN - 0002-9343
VL - 138
SP - 800-808.e2
JO - American Journal of Medicine
JF - American Journal of Medicine
IS - 5
ER -